Health Cartoonist Captures Public Sentiment on Tylenol Controversy The recent controversy surrounding Tylenol has sparked public discourse, compelling cartoonist Dave Whamond to weigh in with his unique perspective. Whamond’s latest cartoon, published... Editorial26 September, 2025
Health Johnson & Johnson’s Imaavy Faces Setback in Arthritis Trials Johnson & Johnson’s new immunology drug, Imaavy, has encountered a significant setback as it failed to meet its primary endpoints in a Phase 2a... Editorial29 August, 2025